about
Plica Neuropathica (Plica polonica) Following Azathioprine-induced PancytopeniaBird's Nest View from a Dermatologist's EyeCutaneous complications of molecular targeted therapy used in oncologyAvoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG)Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Neoadjuvant intra-arterial chemotherapy in patients with primary lacrimal adenoid cystic carcinomaChemotherapy-associated paronychia treated with 2% povidone-iodine: a series of cases.High-dose cytosine arabinoside-induced cutaneous reactions.Skin care management in cancer patients: an evaluation of quality of life and tolerability.Mucocutaneous side effects of antineoplastic chemotherapy.Investigational medications in the treatment of alopecia.Persistent docetaxel-induced supravenous erythematous eruption.Docetaxel Facilitates Endothelial Dysfunction through Oxidative Stress via Modulation of Protein Kinase C Beta: The Protective Effects of Sotrastaurin.Extravasation injuries in adults.Dermatological Findings in Turkish Paediatric Haematology-Oncology Patients.Anthracycline extravasation injuries: management with dexrazoxane.Nail toxicity induced by cancer chemotherapy.Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report.Adverse mucocutaneous reactions related to chemotherapeutic agents: part II.Syringometaplasia: variants and underlying mechanisms.Dermatological adverse events with taxane chemotherapy.Case report of cold-weather-induced radiation recall dermatitis after chemoradiotherapy with cisplatin.Nasal involvement in hand and foot syndrome.Serpentine supravenous hyperpigmentation.Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen.Inflammation of actinic keratosis with combination of alkylating and taxane agents: a case report.Sorafenib (Nexavar®, BAY 43-9006)-induced Hand-foot Skin Reaction with Facial Erythema.Flexural erythematous eruption following autologous peripheral blood stem cell transplantation: a study of four cases.Management of Paclitaxel-induced hand-foot syndrome.[Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].Hand-foot syndrome induced by erlotinib (Tarceva(Ⓡ) ).Squamous syringometaplasia associated with docetaxel.Topotecan-induced celluitis-like fixed drug eruption.Therapy-related cutaneous adverse effects in an Indian cohort of adult leukaemia patients.Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy.Radiation- and chemotherapy-induced permanent alopecia: case series.An unusual presentation of hand-foot syndrome at the hidden area: the scrotum and penis.Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia.Chemotherapy-induced acral erythema with involvement of the face and neck: A case report.Unusual and Interesting Adverse Cutaneous Drug Reactions.
P2860
Q24625956-5507B064-A8A2-48AF-BA40-75FEC3FB83E6Q26749069-3CD485E1-C329-477D-BF8F-0433E8C0699CQ28070095-79D25F66-2C82-4898-AD03-A20AE09FC317Q28079359-F1CB538C-8DA9-4C73-A8A9-55F963A98437Q33410375-A027B73E-3F65-4FBF-915B-38A11CED3CEDQ33419911-9F2E64B1-77D9-4F58-B439-A0BD232CDBB4Q33881510-848B016A-94CA-48B8-8E45-A0AC1290E38BQ33962473-EFBB3013-C396-4CCC-B749-F66B3B64F231Q34700294-6C615406-3DF7-4B2C-867F-60FD4FE61946Q35925646-506CEA46-459A-4935-A7F3-616E3948A938Q36065987-3D341B57-7EB9-4118-B293-8683B62D1D24Q36243821-7B7E9414-BB1B-40DE-A00C-E6BFC9FC879FQ36801721-348CDD44-91B7-4249-8854-CDB6B4D8076FQ36877135-C22579D4-ADCB-430F-93E5-1C7C268A53FDQ37146326-CA49F058-4704-46F3-BDCC-2CB9D82B21B5Q37230281-DB8D35DE-9F98-4BDA-92AD-58AACEF3BD1FQ37378229-5ED5098F-87C4-4BFD-982A-BD0260EEECFDQ37719920-4F455F9E-4036-4EB4-9206-5115E97848D8Q37820276-94164973-65B8-42BD-A9B1-1D9872152B44Q38605824-A080999E-8096-4BCA-BA03-CBA2D30FC8C7Q38934447-F51BCD19-53DB-4C09-AFA0-D576CBEE0D34Q39216303-2E67985D-C8F0-48DD-AE31-2929181E773DQ40806608-2649F53B-876E-40E7-A175-0DF06FCBAF56Q41599795-6D33A7D9-CE5C-4ADE-B487-3E9966475FA7Q41844472-78EC90CA-242C-4AF1-B327-0EBF22623B9AQ41967737-63005C94-41CC-4A3D-B21D-B9A6F7D6C7F9Q42089287-7DB0D4C0-FD62-4722-A9AD-E10B7B11CD06Q42509459-FE442CED-3254-4D90-916D-7F93F983F734Q43067021-534F0B6E-C89C-474C-9F4D-7F8B102CD119Q43256210-D84527E6-C78A-49B8-8D89-052CFBCCED63Q43438561-FBAF3493-5206-4E1E-8E36-1AD6D5DDE33BQ43958933-0A1F018B-A9A6-431D-8BC7-645A98C54BC2Q44133012-511D17A5-1D41-4BD7-A9F6-9BEFF91DFFACQ44502795-E03DDFB8-88B4-4734-B251-7DB77B0856CBQ44973093-6B7E0937-0572-41E1-A7B4-EB3ED23EDF1EQ45424604-09F50F1E-A6CF-4D40-976B-189894AAD246Q46069818-550B840E-0E4A-4FFB-BC5D-726ABD5E52CCQ46630218-11D39F68-3311-44B9-A940-9ADD31908747Q54482569-D87953EB-5F74-4C24-927D-E939636C768DQ55099672-DE6F0059-0B74-4099-960A-8E11301B2FAE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mucocutaneous reactions to chemotherapy.
@ast
Mucocutaneous reactions to chemotherapy.
@en
Mucocutaneous reactions to chemotherapy.
@nl
type
label
Mucocutaneous reactions to chemotherapy.
@ast
Mucocutaneous reactions to chemotherapy.
@en
Mucocutaneous reactions to chemotherapy.
@nl
prefLabel
Mucocutaneous reactions to chemotherapy.
@ast
Mucocutaneous reactions to chemotherapy.
@en
Mucocutaneous reactions to chemotherapy.
@nl
P2093
P1476
Mucocutaneous reactions to chemotherapy.
@en
P2093
D L Whitaker-Worth
J M Grant-Kels
W S Susser
P304
367-98; quiz 399-400
P356
10.1016/S0190-9622(99)70488-3
P407
P577
1999-03-01T00:00:00Z